MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

3.39 -8.38

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.32

Max

3.71

Schlüsselkennzahlen

By Trading Economics

Einkommen

30M

-21M

Verkäufe

35M

480M

Gewinnspanne

-4.351

Angestellte

4,500

EBITDA

512K

15M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+136.8% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

19. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-349M

430M

Vorheriger Eröffnungskurs

11.77

Vorheriger Schlusskurs

3.39

Nachrichtenstimmung

By Acuity

25%

75%

47 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Jan. 2026, 23:07 UTC

Ergebnisse

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27. Jan. 2026, 21:27 UTC

Ergebnisse

Texas Instruments 4Q Sales Rise, Profit Falls

27. Jan. 2026, 23:55 UTC

Market Talk

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27. Jan. 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. Jan. 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27. Jan. 2026, 23:39 UTC

Market Talk

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27. Jan. 2026, 23:20 UTC

Ergebnisse

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27. Jan. 2026, 23:20 UTC

Ergebnisse

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27. Jan. 2026, 23:19 UTC

Ergebnisse

SK Innovation Posts Net Loss for Second Consecutive Year

27. Jan. 2026, 23:19 UTC

Ergebnisse

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27. Jan. 2026, 23:18 UTC

Ergebnisse

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27. Jan. 2026, 23:18 UTC

Ergebnisse

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27. Jan. 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

27. Jan. 2026, 23:11 UTC

Market Talk

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27. Jan. 2026, 23:07 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27. Jan. 2026, 22:17 UTC

Market Talk

U.S. Dollar Slips Following Trump Comments -- Market Talk

27. Jan. 2026, 22:06 UTC

Ergebnisse

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27. Jan. 2026, 21:51 UTC

Ergebnisse

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. Jan. 2026, 21:43 UTC

Ergebnisse

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27. Jan. 2026, 21:41 UTC

Ergebnisse

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27. Jan. 2026, 21:38 UTC

Ergebnisse

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27. Jan. 2026, 21:32 UTC

Ergebnisse

Ampol: Modest Profit From F&I International in 2025

27. Jan. 2026, 21:32 UTC

Ergebnisse

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27. Jan. 2026, 21:31 UTC

Ergebnisse

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27. Jan. 2026, 21:31 UTC

Ergebnisse

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27. Jan. 2026, 21:30 UTC

Ergebnisse

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27. Jan. 2026, 21:29 UTC

Ergebnisse

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27. Jan. 2026, 21:29 UTC

Ergebnisse

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27. Jan. 2026, 21:28 UTC

Ergebnisse

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

136.8% Vorteil

12-Monats-Prognose

Durchschnitt 9.33 USD  136.8%

Hoch 16 USD

Tief 5 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

14 ratings

13

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

47 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat